ABCG2 is overexpressed on red blood cells in Ph-negative myeloproliferative neoplasms and potentiates ruxolitinib-induced apoptosis
Ralfs Buks, Mégane Brusson, Sylvie Cochet, Tatiana Galochkina, Bruno Cassinat, Ivan Nemazanyy, Thierry Peyrard, Jean Jacques Kiladjian, Alexandre G. de Brevern, Slim Azouzi, Wassim El Nemer* (Corresponding Author)
Dive into the research topics of 'ABCG2 is overexpressed on red blood cells in Ph-negative myeloproliferative neoplasms and potentiates ruxolitinib-induced apoptosis'. Together they form a unique fingerprint.